Home/Filings/4/0001213900-22-069754
4//SEC Filing

Grauch Edward Rowland 4

Accession 0001213900-22-069754

CIK 0001000683other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 4:20 PM ET

Size

6.7 KB

Accession

0001213900-22-069754

Insider Transaction Report

Form 4
Period: 2022-11-04
Grauch Edward Rowland
Executive Vice President & COO
Transactions
  • Award

    Common Stock, par value $0.001

    2022-11-04$0.18/sh+5,769$1,0381,042,910 total
  • Award

    Common Stock, par value $0.001

    2022-11-04$0.18/sh+50,725$9,1311,093,635 total
Footnotes (1)
  • [F1]Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the OTCQB on such date).

Documents

1 file

Issuer

BLONDER TONGUE LABORATORIES INC

CIK 0001000683

Entity typeother

Related Parties

1
  • filerCIK 0001757536

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:20 PM ET
Size
6.7 KB